Global DATS Market to reach USD 6620.8 million by 2027.
Global DATS Market valued approximately USD 728 million in 2019 is anticipated to grow with a healthy growth rate of more than 27.8% over the forecast period 2020-2027. Major drivers of the dynamic application security testing market include the increasing degree of business risks due to application vulnerabilities, stringent government regulations, increasing sophistication level of cyber-attacks, and growing adoption of third-party applications.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
 By Type
 Solution
 Service
 By Application
 Web Application Security
 Mobile Application Security
 By Deployment Mode
 On-Premises
 Cloud
 By Vertical
 Government & Defense
 BFSI
 IT & Telecom
 Healthcare
 Retail
 Manufacturing
 Others
 By Organization Size
 SMEs
 Large Enterprises
By Regions:
 North America
 U.S.
 Canada
 Europe
 UK
 Germany
 Asia Pacific
 China
 India
 Japan
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015 to 2018
Base year – 2019
Forecast period – 2020 to 2027
Some of the key manufacturers involved in the market are IBM, Micro Focus, Synopsys, Veracode, Whitehat Security, Accenture, Pradeo, Rapid7, Tieto, Trustwaven Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Global DATS in Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Chapter 1. North America Hemoglobin Testing Market Definition and Scope
1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation
Chapter 2. Research Methodology
2.1. Research Process
2.1.1. Data Mining
2.1.2. Analysis
2.1.3. Market Estimation
2.1.4. Validation
2.1.5. Publishing
2.2. Research Assumption
Chapter 3. Executive Summary
3.1. Global & Segmental Market Estimates & Forecasts, 2015-2027 (USD Billion)
3.2. Key Trends
Chapter 4. North America Hemoglobin Testing Market Dynamics
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
Chapter 5. North America Hemoglobin Testing Market, By Application
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. North America Hemoglobin Testing Market, Sub Segment Analysis
5.3.1. Hospitals
5.3.1.1. Market estimates & forecasts, 2015-2027 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2015-2027 (USD Billion)
5.3.2. Research Centres
5.3.2.1. Market estimates & forecasts, 2015-2027 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2015-2027 (USD Billion)
5.3.3. Laboratories
5.3.3.1. Market estimates & forecasts, 2015-2027 (USD Billion)
5.3.3.2. Regional breakdown estimates & forecasts, 2015-2027 (USD Billion)
5.3.4. Physicians Clinic
5.3.4.1. Market estimates & forecasts, 2015-2027 (USD Billion)
5.3.4.2. Regional breakdown estimates & forecasts, 2015-2027 (USD Billion)
5.3.5. Retail Clinics
5.3.5.1. Market estimates & forecasts, 2015-2027 (USD Billion)
5.3.5.2. Regional breakdown estimates & forecasts, 2015-2027 (USD Billion)
5.3.6. Pediatrics
5.3.6.1. Market estimates & forecasts, 2015-2027 (USD Billion)
5.3.6.2. Regional breakdown estimates & forecasts, 2015-2027 (USD Billion)
5.3.7. Nursing Homes
5.3.7.1. Market estimates & forecasts, 2015-2027 (USD Billion)
5.3.7.2. Regional breakdown estimates & forecasts, 2015-2027 (USD Billion)
5.3.8. Ambulatory Healthcare Services
5.3.8.1. Market estimates & forecasts, 2015-2027 (USD Billion)
5.3.8.2. Regional breakdown estimates & forecasts, 2015-2027 (USD Billion)
5.3.9. Homecare
5.3.9.1. Market estimates & forecasts, 2015-2027 (USD Billion)
5.3.9.2. Regional breakdown estimates & forecasts, 2015-2027 (USD Billion)
5.3.10. Others
5.3.10.1. Market estimates & forecasts, 2015-2027 (USD Billion)
5.3.10.2. Regional breakdown estimates & forecasts, 2015-2027 (USD Billion)
Chapter 6. North America Hemoglobin Testing Market, by Regional Analysis
6.1. North Market, Regional Market Snapshot (2015-2027)
6.2. North America Hemoglobin Testing Market Snapshot
6.2.1. U.S.
6.2.1.1. Market estimates & forecasts, 2015-2027 (USD Billion)
6.2.1.2. Application breakdown estimates & forecasts, 2015-2027 (USD Billion)
6.2.2. Canada
6.2.2.1. Market estimates & forecasts, 2015-2027 (USD Billion)
6.2.2.2. Application breakdown estimates & forecasts, 2015-2027 (USD Billion)
Chapter 7. Competitive Intelligence
7.1. Company Market Share (Subject to Data Availability)
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Abbott Laboratories
7.3.1.1. Overview
7.3.1.2. Financial (Subject to Data Availability)
7.3.1.3. Product Summary
7.3.1.4. Recent Developments
7.2.2 Danaher,
7.3.2. F. Hoffmann-La Roche
7.3.3. Bayer Medical Care
7.3.4. Bio-Rad Laboratories
7.3.5. Diazyme Laboratories
7.3.6. Epinex Diagnostics
7.3.7. Fisher Scientific
7.3.8. Acon Laboratories
7.3.9. Alere